Next-Generation Biomanufacturing Market worth $43.16 Billion by 2030 - Exclusive Report by InsightAce Analytic
According to the latest research by InsightAce Analytic, the global next-generation biomanufacturing market is valued at US$ 19.85 Billion in 2021, and it is expected to reach US$ 43.16 Billion by 2030, with a CAGR of 9.3% during the forecast period of 2022-2030.
- According to the latest research by InsightAce Analytic, the global next-generation biomanufacturing market is valued at US$ 19.85 Billion in 2021, and it is expected to reach US$ 43.16 Billion by 2030, with a CAGR of 9.3% during the forecast period of 2022-2030.
- Next-generation biomanufacturing services allow the development and manufacturing of a wide range of products with the highest level of quality than the first generation biomanufacturing products.
- These services focus on single-use technologies such as single-use bio-containers and single-use bioreactors, enabling better process flexibility and efficiency.
- In November 2020, Merck (Germany) collaborated with Transcenta, a biotherapeutics company, to implement & advance continuous manufacturing for protein therapeutics.